Advancements in Genetic Engineering
Open Access

Travis Dunckley

Biography

Dr. Dunckley obtained his undergraduate degree in molecular and cellular biology and biochemistry from the University of Arizona. His doctoral work was completed at the University of Arizona in the field of molecular and cellular biology. Prior to joining TGen, he studied gene expression at the level of mRNA stability. In 2000, Dr. Dunckley expanded his training to the field of Neurobiology during a fellowship position at Barrow Neurological Institute. While there he investigated structure/function interactions in nicotinic acetylcholine receptors (nAChR) and identified novel genes regulated by nAChR activity. In 2003 he transitioned to the Neurogenomics Division at TGen where he is currently applying genomic and molecular techniques toward therapeutic development in neurodegenerative diseases, with a specific focus on AD and Parkinsons disease 

Research Interest

Development of Alzheimer's disease (AD) therapeutics targeting tau protein patholoy

Development of therapeutics targeting a-synuclein protein dysfunction and pathology in Parkinson's disease (PD)

High-throughput RNA interference screening

Whole-genome expression profiling